Skip to main content
TipRanks
Go Ultimate75% OFF

Alan Musso Insider Profile

4 Followers

Alan Musso, CFO at Fulcrum Therapeutics, holds ― shares in Fulcrum Therapeutics (Ticker: FULC), holds 26.55K shares in Bellicum Pharmaceuticals (Ticker: BLCM), holds ― shares in Rein Therapeutics (Ticker: RNTX).

Alan Musso's Trading History

BLCM
Bellicum Pharmaceuticals
May 29, 2018―Uninformative Sell49.46K$1.96K
GYRE
Gyre Therapeutics
Oct 21, 2014SVP, Fin+Admin, CFO & TreasUninformative Buy―$253.74K
RNTX
Rein Therapeutics
―Director――
FULC
Fulcrum Therapeutics
―CFO――

You May Also Like

Alan Musso insider profile FAQ

What is the percentage of profitable transactions made by Alan Musso?
The percentage of profitable transactions made by Alan Musso is 0%.
What is the average return per transaction made by Alan Musso?
The average return per transaction made by Alan Musso is -14.70%.
What stocks does Alan Musso hold?
Alan Musso holds: FULC, BLCM, RNTX, GYRE stocks.
What was Alan Musso's most profitable transaction?
Alan Musso’s most profitable transaction was an Informative Sell of GYRE stock on December 15, 2009. The return on the trade was -11.40%.
What is Alan Musso's role in Fulcrum Therapeutics?
Alan Musso's role in Fulcrum Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.